14 Jun 2018 – Destiny Pharma notes FDA statement on their focus to enable new approaches to fight AMR
News
Thursday June 14, 2018
14 Jun 2018 – Destiny Pharma notes FDA statement on their focus to enable new appr...
Brighton, United Kingdom – 14 June 2018 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the development of novel anti-microbial drugs, which address the global problem […]